Description
Prevention and protective adjuvant treatment for actinic keratosis (AK) and other forms of non-melanoma skin cancer (NMSC).
Reduces and improves the subclinical cutaneous cancerisation field associated with actinic keratosis and non-melanoma skin cancer.
With DNA Repairsomes, ISDIN patented technology that reduces and improves the subclinical cutaneous cancerization field associated with actinic keratosis and non-melanoma skin cancer.
Prevents actinic damage caused by the sun and encourages its repair. Creates a protective film of ADN Repairsomes on the skin that helps to protect against new lesions.
Furthermore, continued use helps DNA's natural repair mechanism.
How to use:
Apply liberally to the affected area twice a day, in the morning and at midday. Photolyase is activated by visible light.
